Monday, July 4, 2022

Must Reads: Week In Review: Henlius Signs $196 Million Deal For 2 Oncology Bifunctional Sialidase Candidates

Shanghai Henlius Biotech acquired Greater China rights to two early-stage bifunctional sialidase candidates from Palleon

No comments:

Post a Comment

Rate cut hopes fade

Good morning, it's Amy in Melbourne with your Friday newsletter. Today's must-reads:• RBA rate-cut bets pared on jobs data• ...